Author: V. Alure

Depending on which news article I’ve just read, the FTSE 100 is going gangbusters or on the verge of crisis. From my point of view, the Jekyll and Hyde nature of London’s leading index brings about a few burning questions. Questions like: what’s going on with the FTSE 100? Is the Footsie heading for a terrible crash? Or are there lots and lots great stocks to buy right now (and what are they)? Let’s try and answer them. Image source: Getty Images Tip of iceberg On the surface, the FTSE 100 is going great guns. Record highs keep being broken.…

For years, I reckoned that Vodafone (LSE: VOD) was undervalued. Yet things often seemed to go from bad to worse for the share price, albeit there was a juicy dividend yield by way of compensation. Over the past year, though, the Vodafone share price has soared by 71%. That has brought the dividend yield down to 3.3% — still slightly above the FTSE 100 average. What has driven this share price turnaround – and could there still be more to come? Image source: Vodafone Group plc A growth story again Three decades ago, Vodafone was a great British growth story.…

Renewable power is growing rapidly worldwide. India accounted for about 5% of global renewable capacity in 2024 and ranked as the third-largest contributor after China and the US. India’s installed capacity is projected to rise from 475 GW (Giga Watt) in FY25 to 705 GW by FY30. India’s solar installation costs fell 60.6% and wind costs 20.4% (FY16–FY24), making renewables significantly cheaper than fossil fuels. Renewables’ contribution to generation is projected to increase from 14% in FY25 to 30% by FY30, while thermal power’s share declines to 58%, signalling structural decarbonisation of India’s grid.Key trends: Comments Published on February 24,…

Investors who added Tesco (LSE: TSCO) to their shopping basket a few years ago could now be dancing in the aisles. Tesco shares are up 125% in the past five years. Not only that, but this week they hit a new 15-year high, getting back to levels last seen in 2011. Image source: Tesco plc A market leader, evolving with the times Tesco has changed a lot since 2011. It has reined in its international business, selling off its once large Asian operations and returning funds to shareholders. After a long since resolved accounting scandal in 2014, Tesco had to…

BREAKING Mastercard Incorporated (MA) shares plunged 5.6% to $491.78 during today’s trading session. The sharp move in MA is attracting significant market attention as traders assess the catalyst behind the price action. Full analysis with detailed breakdown coming shortly on AlphaStreet. Source link #Mastercard #Incorporated #Drops #Developing #Story

BREAKING Apple Inc. (AAPL) shares surged 5.1% to $274.44 during today’s trading session. The sharp move in AAPL is attracting significant market attention as traders assess the catalyst behind the price action. Full analysis with detailed breakdown coming shortly on AlphaStreet. Source link #Apple #AAPL #Surges #Developing #Story

Stay informed with free updatesSimply sign up to the Equities myFT Digest — delivered directly to your inbox.Utilities, energy and materials stocks have emerged as winners from the AI anxiety gripping Wall Street, as investors fleeing sectors seen as vulnerable to disruption seek businesses with tangible assets.The S&P 500 software sub-index this week tumbled to its lowest level since the immediate aftermath of President Donald Trump’s “liberation day” tariff announcement last April, losing $1.2tn in combined market capitalisation in less than a month. The sector has borne the brunt of worries that new AI tools could upend entire industries. Those…

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersNovo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027, in a bid to make the treatments more accessible to patients with insurance coverage. The obesity injection Wegovy, its new pill counterpart, the diabetes shot Ozempic and the oral diabetes drug Rybelsus will have a new lower list price of $675 per month starting on Jan. 1, 2027. The…

Geron earnings up next: Can RYTELO sustain revenue momentum? Source link #Geron #earnings #RYTELO #sustain #revenue #momentum

India’s retail inflation, which has stayed below the Reserve Bank of India’s (RBI’s) 4 per cent target in recent times, is likely to remain benign in the coming months, RBI Deputy Governor Poonam Gupta said in a speech on Friday, which was uploaded on the central bank’s website on Tuesday.   Headline inflation dipped to multi-year lows of around 1.5-2.8 per cent in late 2025. Latest data under the updated series showed retail inflation was at 2.75 per cent in January 2026. Under the revised Consumer Price Index (CPI) series, with 2024 as the new base year replacing…